Peter Selby

Prof Selby trained in medicine at Cambridge and Birmingham and then worked for the Medical Research Council at their mineral metabolism unit in Leeds where he developed his interest in metabolic bone disease. He completed his training in endocrinology at Newcastle and moved to Manchester in 1990.

Prof Selby’s clinical interests are in the field of endocrinology especially calcium metabolism and bone disease. He is actively involved in postgraduate training and is currently chair of the Specialty Advisory Committee in Endocrinology and Diabetes. His main academic interests are the effect of non-skeletal diseases on bone and vitamin D along with the assessment and treatment of osteoporosis. Prof Selby is director of the Supraregional Assay Service Vitamin D laboratory at the MRI. He is a scientific adviser to the National Osteoporosis Society, the National Association for the Relief of Paget's disease, Hypoparathyroidism UK and an international adviser to the Paget Foundation in the United States. He is a member of a NICE technology assessment committee and has contributed to the NICE clinical guideline on osteoporosis risk assessment.